Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07817797 | Paravertebral Block and Reduction in Opioid Consumption After Mastectomy(BPV-MAST) | completed | N/A | 40 | University Tunis El ManarOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT07817979 | TENS, Compression, and Cryotherapy for Paclitaxel-Induced Peripheral Neuropathy in Women With Breast Cancer | completed | N/A | 140 | Cumhuriyet UniversityOTHER | 1 | Sep 14, 2026 | clinicaltrials |
| NCT06033092 | Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion(TOLERANT) | completed | Phase 2 | 110 | European Institute of OncologyOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT07079436 | EIT Evaluation of Pulmonary Ventilation With Different Ropivacaine Concentrations in Intercostal Nerve Blockade(EIT) | completed | N/A | 67 | Fudan UniversityOTHER | 1 | Sep 10, 2026 | clinicaltrials |
| NCT03414684 | Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer | completed | Phase 2 | 78 | Dana-Farber Cancer InstituteOTHER | 1 | Sep 9, 2026 | clinicaltrials |
| NCT01620359 | Study of ExAblate Focused Ultrasound Ablation of Breast Cancer | completed | Phase 2 | 14 | InSightecINDUSTRY | 1 | Sep 8, 2026 | clinicaltrials |
| NCT02794558 | Safety and Effectiveness of MR Guided Focused Ultrasound Surgery in the Treatment of Early Breast Carcinomas | completed | N/A | 91 | InSightecINDUSTRY | 1 | Sep 8, 2026 | clinicaltrials |
| NCT05968157 | MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick | completed | N/A | 145 | University of Massachusetts, WorcesterOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT07807605 | Ultrasound Guided Serratus Anterior Plane Block Versus Ultrasound Guided Thoracic Epidural Analgesia | completed | N/A | 70 | Beni-Suef UniversityOTHER | 1 | Sep 8, 2026 | clinicaltrials |
| NCT01251900 | BRCA Mutations in Latinas | completed | — | 266 | National Cancer Institute (NCI)NIH | 1 | Sep 4, 2026 | clinicaltrials |
| NCT04016376 | Study of Nerve Block Pain Management in Patients Undergoing a Double Mastectomy With Immediate Reconstruction | completed | Phase 4 | 1,507 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT07724678 | Comparison of Combined (Superficial and Deep) and Isolated Deep Serratus Anterior Plane Blocks After Breast Surgery | completed | — | 76 | SBU Ankara Egitim ve Arastirma HastanesiOTHER | 1 | Sep 4, 2026 | clinicaltrials |
| NCT03856372 | Hypofractionated Vs Conventional Fractionated Postmastectomy Radiotherapy for High Risk Breast Cancer | completed | N/A | 1,494 | Fudan UniversityOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT06827132 | Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast Cancer(CASCADE) | completed | — | 603 | AstraZenecaINDUSTRY | 2 | Sep 3, 2026 | clinicaltrials |
| NCT07803549 | The Effect of Self-Management Interventions Among Patients With Breast Cancer Related-Lymphedema((BCRL)) | completed | N/A | 100 | Al-Zaytoonah University of JordanOTHER | 1 | Sep 3, 2026 | clinicaltrials |
| NCT02271828 | Omitting Sentinel Node Procedure in Breast Cancer Patients Undergoing Breast Conserving Therapy | completed | N/A | 1,644 | Maastricht University Medical CenterOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT04276493 | Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab | completed | Phase 1 / Phase 2 | 71 | BeiGeneINDUSTRY | 3 | Sep 2, 2026 | clinicaltrials |
| NCT05864144 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 98 | Sensei Biotherapeutics, Inc.INDUSTRY | 1 | Sep 2, 2026 | clinicaltrials |
| NCT07798895 | Opioid-Free Versus Opioid-Based Anesthesia in Modified Radical Mastectomy | completed | N/A | 28 | Muhammad Fiqhi AmiruddinOTHER | 1 | Sep 2, 2026 | clinicaltrials |
| NCT00553410 | Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer(SOLE) | completed | Phase 3 | 4,884 | ETOP IBCSG Partners FoundationNETWORK | 20 | Sep 1, 2026 | clinicaltrials |
| NCT02997553 | Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery(GASVERT) | completed | Phase 3 | 744 | Institut de Cancérologie de LorraineOTHER | 1 | Sep 1, 2026 | clinicaltrials |
| NCT00469339 | Risk Communication Within Mexican-American Families | completed | — | 498 | National Human Genome Research Institute (NHGRI)NIH | 1 | Aug 31, 2026 | clinicaltrials |
| NCT03944226 | Is Dietary Nitrate Effective in Reducing Aerobic Glycolysis in Breast Cancer?(BEET) | completed | N/A | 1 | University of AberdeenOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT05150652 | Neoadjuvant Endocrine Therapy in ER-positive, HER2-negative Early Stage Breast Cancer | completed | Phase 2 | 8 | Irada Ibrahim-zadaOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT05268913 | Towards Early Detection of Breast Cancer in High Risk Population(READ RISK) | completed | — | 30 | University of AberdeenOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT05838417 | Promoting Informed Choice for Breast Cancer Screening: A Longitudinal Study | completed | N/A | 499 | University of Colorado, DenverOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT00601900 | Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer | completed | Phase 3 | 394 | National Cancer Institute (NCI)NIH | 2 | Aug 28, 2026 | clinicaltrials |
| NCT03949946 | Is Lipid Mapping an Effective Early Detection Tool for Breast Cancer in High-risk Populations? | completed | — | 40 | University of AberdeenOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT06234488 | Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study | completed | — | 125 | Medical College of WisconsinOTHER | 1 | Aug 27, 2026 | clinicaltrials |
| NCT00066690 | Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer(SOFT) | completed | Phase 3 | 3,066 | ETOP IBCSG Partners FoundationNETWORK | 3 | Aug 26, 2026 | clinicaltrials |
| NCT02536742 | Palbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer(PYTHIA) | completed | Phase 2 | 124 | ETOP IBCSG Partners FoundationNETWORK | 3 | Aug 26, 2026 | clinicaltrials |
| NCT03644186 | To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)(TOUCH) | completed | Phase 2 | 147 | ETOP IBCSG Partners FoundationNETWORK | 4 | Aug 26, 2026 | clinicaltrials |
| NCT04579107 | KARMA Kontrast Evaluating Contrast Enhanced Mammography in Early Detection of Breast Cancer | completed | N/A | 300 | Karolinska InstitutetOTHER | 1 | Aug 26, 2026 | clinicaltrials |
| NCT05176860 | Evaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy | completed | N/A | 31 | Varian, a Siemens Healthineers CompanyINDUSTRY | 1 | Aug 26, 2026 | clinicaltrials |
| NCT04670445 | Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer(UPLIFT) | completed | N/A | 199 | Massachusetts General HospitalOTHER | 1 | Aug 25, 2026 | clinicaltrials |
| NCT07782866 | MindVybe tVNS/APS for Wellbeing in Breast Cancer Survivors | completed | N/A | 46 | The Healing Consciousness FoundationOTHER | 1 | Aug 24, 2026 | clinicaltrials |
| NCT06384417 | Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2 | completed | N/A | 30 | Milton S. Hershey Medical CenterOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT07778407 | TDXD in Metastatic HER2-Positive Breast Cancer | completed | — | 25 | Mansoura UniversityOTHER | 1 | Aug 21, 2026 | clinicaltrials |
| NCT04902872 | Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors | completed | Phase 1 / Phase 2 | 69 | Cybrexa TherapeuticsINDUSTRY | 1 | Aug 20, 2026 | clinicaltrials |
| NCT07216274 | Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer | completed | N/A | 26 | Mayo ClinicOTHER | 1 | Aug 20, 2026 | clinicaltrials |
| NCT01791478 | BYL719 and Letrozole in Post-Menopausal Patients With Hormone Receptor-Positive Metastatic Breast Cancer | completed | Phase 1 | 46 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT05545150 | Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study | completed | Phase 2 | 113 | Northwestern UniversityOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT05889728 | Pilot Trial to Assess 68Ga Bombesin PET/CT (NeoB) Imaging for Staging of Breast Cancer | completed | Phase 2 | 20 | St Vincent's Hospital, SydneyOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT06865534 | Large Language Models to Aid Gynecological Oncology Treatment(EASING) | completed | N/A | 70 | Philipps University MarburgOTHER | 1 | Aug 19, 2026 | clinicaltrials |
| NCT03096054 | A Phase I Trial of LY3143921 Hydrate in Solid Tumours | completed | Phase 1 | 69 | Cancer Research UKOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT05162846 | Michigan Genetic Hereditary Testing (MiGHT)(MiGHT) | completed | N/A | 793 | University of Michigan Rogel Cancer CenterOTHER | 1 | Aug 18, 2026 | clinicaltrials |
| NCT06047184 | Phase I Study of BEBT-209 in Women With Advanced Breast Cancer | completed | Phase 1 | 100 | BeBetter Med IncINDUSTRY | 1 | Aug 18, 2026 | clinicaltrials |
| NCT06685796 | A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer | completed | Phase 2 | 65 | BeBetter Med IncINDUSTRY | 1 | Aug 18, 2026 | clinicaltrials |
Data updated 16 days agoSource updated Sep 14, 2026source: clinicaltrials